Identifying Patients at Risk of Delayed Breast Imaging Due to the COVID-19 Pandemic.
breast cancer care
breast imaging
cancer screening
covid-19
delayed care
screening mammography
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
accepted:
16
08
2021
entrez:
20
9
2021
pubmed:
21
9
2021
medline:
21
9
2021
Statut:
epublish
Résumé
Epidemiological models predict worse cancer outcomes due to COVID-19 pandemic-related delays in cancer surveillance and treatment. This study evaluated patient demographic factors associated with delayed breast imaging or procedure appointments due to COVID-19. Patients attending a breast imaging or procedure appointment at the Pennsylvania Hospital Breast Center from December 28, 2020 to January 31, 2021 were asked to complete a voluntary and anonymous survey on the impact of COVID-19. Chi-squared and two-sample t-tests were used to analyze correlations between having a delayed appointment and various demographic variables. Five hundred seventy patients completed the survey. Participants were more likely to have delayed a breast imaging or procedure appointment if they were younger (53.9 versus 57.4 years old, p=0.014), had more total household residents (2.7 versus 2.2, p=0.019) or children (0.8 versus 0.4, p=0.016), personally had COVID-19 (p=0.04), or personally had to quarantine (p<0.01). Race, ethnicity, education, income level, and marital status were not found to statistically significantly correlate with having a delayed appointment. This study found that younger age, a greater number of residents and children in the household, and having a personal history of COVID-19 infection or quarantining were factors significantly correlated with delaying a breast imaging or procedure appointment. As radiology practices prepare to mitigate the impact of COVID-19 on screening practices and cancer outcomes, these findings may help imaging centers refine patient outreach efforts and policy accommodations to protect the most vulnerable populations.
Identifiants
pubmed: 34540462
doi: 10.7759/cureus.17235
pmc: PMC8443468
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e17235Informations de copyright
Copyright © 2021, Li et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cancer. 2020 Oct 15;126(20):4466-4472
pubmed: 32749697
Science. 2020 Jun 19;368(6497):1290
pubmed: 32554570
Lancet Oncol. 2020 Aug;21(8):1035-1044
pubmed: 32702311
In Vivo. 2020 Jun;34(3 Suppl):1651-1659
pubmed: 32503825
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
JAMA Netw Open. 2020 Aug 3;3(8):e2017267
pubmed: 32749465
Breast Cancer Res Treat. 2020 Jun;181(3):487-497
pubmed: 32333293
Breast Cancer Res Treat. 2020 Nov;184(1):249-254
pubmed: 32772225
Breast J. 2020 Nov;26(11):2316-2319
pubmed: 32881180
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
Radiol Clin North Am. 2021 Jan;59(1):1-11
pubmed: 33222992
Cancer. 2020 Dec 15;126(24):5202-5205
pubmed: 32914864
J Am Coll Radiol. 2020 Jul;17(7):865-872
pubmed: 32425710